BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8840659)

  • 1. NESTROFT as a screening test for the detection of thalassaemia & common haemoglobinopathies--an evaluation against a high performance liquid chromatographic method.
    Thomas S; Srivastava A; Jeyaseelan L; Dennison D; Chandy M
    Indian J Med Res; 1996 Aug; 104():194-7. PubMed ID: 8840659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NESTROFF as a screening test for detection of Beta-thalassemia trait.
    Bobhate SK; Gaikwad ST; Bhaledrao T
    Indian J Pathol Microbiol; 2002 Jul; 45(3):265-7. PubMed ID: 12785163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of naked eye single tube red cell osmotic fragility test in detecting beta-thalassemia trait.
    Raghavan K; Lokeshwar MR; Birewar N; Nigam V; Manglani MV; Raju NB
    Indian Pediatr; 1991 May; 28(5):469-72. PubMed ID: 1752672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye.
    Mohapatra R; Warang P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2016 May; 90(3):279-84. PubMed ID: 25515688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting beta-thalassaemia trait.
    Singh SP; Gupta SC
    Singapore Med J; 2008 Oct; 49(10):823-6. PubMed ID: 18946618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'NESTROFT'--an effective screening test for beta thalassemia trait.
    Manglani M; Lokeshwar MR; Vani VG; Bhatia N; Mhaskar V
    Indian Pediatr; 1997 Aug; 34(8):702-7. PubMed ID: 9492398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is NESTROFT sufficient for mass screening for beta-thalassaemia trait?
    Mamtani M; Das K; Jawahirani A; Rughwani V; Kulkarni H
    J Med Screen; 2007; 14(4):169-73. PubMed ID: 18078560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia.
    Mamtani M; Jawahirani A; Das K; Rughwani V; Kulkarni H
    Hematology; 2006 Aug; 11(4):277-86. PubMed ID: 17178668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of β-Thalassemia and hemoglobin E in two migrant populations of Manipur, North East India.
    Achoubi N; Asghar M; Saraswathy KN; Murry B
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1195-200. PubMed ID: 23057593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of Nestroft in screening and diagnosis of beta-thalassemia trait.
    Gomber S; Sanjeev ; Madan N
    J Trop Pediatr; 1997 Dec; 43(6):363-6. PubMed ID: 9476460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia.
    Fucharoen G; Sanchaisuriya K; Sae-ung N; Dangwibul S; Fucharoen S
    Bull World Health Organ; 2004 May; 82(5):364-72. PubMed ID: 15298227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple screening test for the detection of heterozygous beta thalassemia.
    Thool AA; Walde MS; Shrikhande AV; Talib VH
    Indian J Pathol Microbiol; 1998 Oct; 41(4):423-6. PubMed ID: 9866902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of single-tube osmotic fragility as a screening test for thalassemia.
    Chow J; Phelan L; Bain BJ
    Am J Hematol; 2005 Jul; 79(3):198-201. PubMed ID: 15981230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the single tube osmotic fragility test in detection of β-thalassaemia trait.
    Gorakshaker AC; Colah R; Nadkarni A; Desai S
    Natl Med J India; 1990; 3(4):171-173. PubMed ID: 29843344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of haemoglobin variants for the diagnosis of beta thalassaemia & other haemoglobinopathies using anion exchange high performance liquid chromatography.
    Rao VB; Bannerjee MK; Shewale LH; Panthaki MH; Bandodkar SB
    Indian J Med Res; 1996 Dec; 104():365-73. PubMed ID: 8996938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalassaemia screening in a non-prevalent region of a prevalent country (Turkey): is it necessary?
    Acemoglu H; Beyhun NE; Vancelik S; Polat H; Guraksin A
    Public Health; 2008 Jun; 122(6):620-4. PubMed ID: 18222509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fast protein liquid chromatography (FPLC) with HPLC, electrophoresis & microcolumn chromatography techniques for the diagnosis of beta-thalassaemia.
    Tangvarasittichai S; Tangvarasittichai O; Jermnim N
    Indian J Med Res; 2009 Mar; 129(3):242-8. PubMed ID: 19491415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advantages in the use of high performance liquid chromatography technique for screening hemoglobinopathies in Venezuela].
    Bravo-Urquiola M; Arends A; Montilla S; Velásquez D; Garcìa G; Alvarez M; Guevara J; Castillo O
    Invest Clin; 2004 Dec; 45(4):309-15. PubMed ID: 15602897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden.
    Gosavi M; Chavan R; Bellad MB
    J Lab Physicians; 2021 Dec; 13(4):368-373. PubMed ID: 34975258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.